Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

New acne treatments show promise as alternatives to traditional therapies.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

A woman developed a persistent skin rash and hair loss from a condition linked to her increased L-tryptophan intake.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Skin cell-derived vesicles can help heal skin injuries effectively.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

The article helps identify common, non-harmful skin conditions in newborns to avoid undue concern and treatment.